Dixon Hubard Feinour & Brown’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-7,670
Closed -$206K 202
2017
Q4
$206K Buy
+7,670
New +$195K 0.06% 179
2016
Q4
Sell
-11,640
Closed -$242K 180
2016
Q3
$242K Sell
11,640
-430
-4% -$10.7K 0.08% 149
2016
Q2
$325K Hold
12,070
0.1% 131
2016
Q1
$337K Sell
12,070
-2,500
-17% -$67K 0.11% 131
2015
Q4
$423K Buy
14,570
+520
+4% +$14.4K 0.13% 118
2015
Q3
$381K Buy
14,050
+1,388
+11% +$39.3K 0.14% 116
2015
Q2
$347K Sell
12,662
-3,788
-23% -$106K 0.11% 130
2015
Q1
$439K Hold
16,450
0.13% 121
2014
Q4
$348K Buy
16,450
+2,200
+15% +$49.1K 0.11% 132
2014
Q3
$339K Buy
14,250
+3,880
+37% +$89.3K 0.11% 132
2014
Q2
$239K Hold
10,370
0.08% 172
2014
Q1
$237K Buy
+10,370
New +$221K 0.08% 167

Other funds holding NVO